Certara QSP, Certara UK Limited, Sheffield, S1 2BJ, UK.
Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Int J Mol Sci. 2023 Jan 17;24(3):1822. doi: 10.3390/ijms24031822.
Chronic nasal carriage of (SA) has been shown to be significantly higher in GPA patients when compared to healthy subjects, as well as being associated with increased endonasal activity and disease relapse. The aim of this study was to investigate SA involvement in GPA by applying a network-based analysis (NBA) approach to publicly available nasal transcriptomic data. Using these data, our NBA pipeline generated a proteinase 3 (PR3) positive ANCA associated vasculitis (AAV) disease network integrating differentially expressed genes, dysregulated transcription factors (TFs), disease-specific genes derived from GWAS studies, drug-target and protein-protein interactions. The PR3+ AAV disease network captured genes previously reported to be dysregulated in AAV associated. A subnetwork focussing on interactions between SA virulence factors and enriched biological processes revealed potential mechanisms for SA's involvement in PR3+ AAV. Immunosuppressant treatment reduced differential expression and absolute TF activities in this subnetwork for patients with inactive nasal disease but not active nasal disease symptoms at the time of sampling. The disease network generated identified the key molecular signatures and highlighted the associated biological processes in PR3+ AAV and revealed potential mechanisms for SA to affect these processes.
慢性鼻腔携带 (SA) 在 GPA 患者中明显高于健康受试者,并且与鼻内活动增加和疾病复发有关。本研究旨在通过应用基于网络的分析(NBA)方法研究 GPA 中 SA 的参与,利用这些数据,我们的 NBA 管道生成了一个蛋白酶 3(PR3)阳性的抗中性粒细胞胞质抗体相关性血管炎(AAV)疾病网络,整合了差异表达基因、失调转录因子(TF)、来自 GWAS 研究的疾病特异性基因、药物靶点和蛋白质-蛋白质相互作用。PR3+AAV 疾病网络捕获了先前报道在 AAV 相关疾病中失调的基因。一个专注于 SA 毒力因子之间相互作用的子网络揭示了 SA 参与 PR3+AAV 的潜在机制。免疫抑制剂治疗降低了无活性鼻病患者样本中该子网络的差异表达和绝对 TF 活性,但不能降低有活性鼻病症状患者的差异表达和绝对 TF 活性。生成的疾病网络确定了 PR3+AAV 的关键分子特征,并强调了相关的生物学过程,并揭示了 SA 影响这些过程的潜在机制。